162 related articles for article (PubMed ID: 21318602)
1. Differential expression of arrestins is a predictor of breast cancer progression and survival.
Michal AM; Peck AR; Tran TH; Liu C; Rimm DL; Rui H; Benovic JL
Breast Cancer Res Treat; 2011 Dec; 130(3):791-807. PubMed ID: 21318602
[TBL] [Abstract][Full Text] [Related]
2. Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development.
Gurevich EV; Benovic JL; Gurevich VV
Neuroscience; 2002; 109(3):421-36. PubMed ID: 11823056
[TBL] [Abstract][Full Text] [Related]
3. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
4. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.
Salazar N; Muñoz D; Kallifatidis G; Singh RK; Jordà M; Lokeshwar BL
Mol Cancer; 2014 Aug; 13():198. PubMed ID: 25168820
[TBL] [Abstract][Full Text] [Related]
5. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
[TBL] [Abstract][Full Text] [Related]
6. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
7. Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.
Lundgren K; Tobin NP; Lehn S; Stål O; Rydén L; Jirström K; Landberg G
J Mol Diagn; 2011 May; 13(3):340-51. PubMed ID: 21497294
[TBL] [Abstract][Full Text] [Related]
8. Do myoepithelial cells hold the key for breast tumor progression?
Polyak K; Hu M
J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):231-47. PubMed ID: 16807803
[TBL] [Abstract][Full Text] [Related]
9. Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.
Rossetti S; Bshara W; Reiners JA; Corlazzoli F; Miller A; Sacchi N
Cancer Lett; 2016 Oct; 380(2):375-383. PubMed ID: 27422542
[TBL] [Abstract][Full Text] [Related]
10. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
11. Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.
Macey TA; Gurevich VV; Neve KA
Mol Pharmacol; 2004 Dec; 66(6):1635-42. PubMed ID: 15361545
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte adhesion-GPCR EMR2 is aberrantly expressed in human breast carcinomas and is associated with patient survival.
Davies JQ; Lin HH; Stacey M; Yona S; Chang GW; Gordon S; Hamann J; Campo L; Han C; Chan P; Fox SB
Oncol Rep; 2011 Mar; 25(3):619-27. PubMed ID: 21174063
[TBL] [Abstract][Full Text] [Related]
13. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.
Bouchal P; Dvořáková M; Roumeliotis T; Bortlíček Z; Ihnatová I; Procházková I; Ho JT; Maryáš J; Imrichová H; Budinská E; Vyzula R; Garbis SD; Vojtěšek B; Nenutil R
Mol Cell Proteomics; 2015 Jul; 14(7):1814-30. PubMed ID: 25903579
[TBL] [Abstract][Full Text] [Related]
14. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal regulation of β
Pearce A; Sanders L; Brighton PJ; Rana S; Konje JC; Willets JM
Cell Signal; 2017 Oct; 38():182-191. PubMed ID: 28733084
[TBL] [Abstract][Full Text] [Related]
17. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
You HJ; How T; Blobe GC
Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
[TBL] [Abstract][Full Text] [Related]
18. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
[TBL] [Abstract][Full Text] [Related]
19. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
[TBL] [Abstract][Full Text] [Related]
20. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
